Publication | Closed Access

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseRheumatic DiseasesImmunologyChronic InflammationAutoimmunityInflammatory Rheumatic DiseasePharmacotherapyRheumatoid Arthritis PatientsTnf-α InhibitorMedicineInflammatory DiseaseRheumatoid Arthritis